KZR - Balance Sheet - Kezar Life Sciences, Inc.

Current Liabilities	20.3 M
Accounts Payable	3.65 M
Short-Term Debt	8.74 M
Other Current Liabilities	7.94 M
Non-Current Liabilities	7.44 M
Long-Term Debt	5.11 M
Other Non-Current Liabilities	2.33 M

Millions

	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2019	Dec-2018	Dec-2017	Dec-2016
ASSETS
Cash & Cash Equivalents	41.7	35.5	40.5	62.9	21.2	15.0	24.2	51.0	9.7
Short Term Investments	90.5	165.9	236.1	145.5	119.2	63.3	83.2	0	0
Receivables	0.4	0	0	0	0	0	0	0	0
Inventory	0	0	0	2.5	2.0	1.2	0	0	0
Other Current Assets	4.8	5.6	9.2	3.3	4.4	2.9	2.4	1.3	0.7
Total Current Assets	137.5	206.9	285.7	211.7	144.8	81.1	109.8	52.3	10.5
PP&E	4.8	8.7	13.2	6.0	6.7	8.1	4.6	1.5	0.9
Intangible Assets	0	0	0	0	0	0	0	0	0
Goodwill	0	0	0	0	0	0	0	0	0
Long Term Investments	0	0	0	0	0	0	0	13 K	13 K
Other Long Term Assets	2.4	5.6	0.7	0.3	0.3	0.3	0.3	0.3	62 K
Other Assets	0	0	0	0	0	0	0	0	0
Total Assets	144.7	221.2	299.6	217.9	151.8	89.5	114.7	54.2	11.4
LIABILITIES
Accounts Payable	3.7	8.3	2.5	2.0	2.4	0.8	0.2	0.5	0.5
Short Term Debt	8.7	3.0	5.1	2.4	2.1	1.8	0	0	0
Other Current Liabilities	7.9	6.5	3.4	3.8	2.0	3.4	3.1	0.9	0.2
Total Current Liabilities	20.3	17.7	11.0	8.2	6.4	6.0	3.3	1.5	0.7
Long Term Debt	5.1	15.9	18.7	12.8	8.8	10.9	0	0	0
Deferred Tax Income	0	0	0	0	0	0	0	0	0
Other Liabilities	2.3	0	0	0	(4.4)	(5.5)	2.5	78.4	28.2
Total Liabilities	27.8	33.7	29.7	21.1	10.9	11.5	5.9	79.9	28.9
EQUITY
Common Stock	7 K	73 K	68 K	56 K	46 K	19 K	19 K	1 K	1 K
Retained Earnings	(434.5)	(350.8)	(248.9)	(180.7)	(126.0)	(84.3)	(49.2)	(26.0)	(17.5)
Other Accumulative Comprehensive Income/Loss	(0.2)	(0.1)	(0.9)	(0.3)	(0.1)	(0.2)	(0.2)	(0.1)	(0.1)
Total Equity	116.9	187.6	269.9	196.9	141.0	78.0	108.8	(25.7)	(17.4)
Total Liabilities and Equity	144.7	221.2	299.6	217.9	151.8	89.5	114.7	54.2	11.4
SHARES OUTSTANDING
Common Shares Outstanding	72.9	72.6	67.4	52.8	44.0	19.1	10.3	13.0	13.0

Free